Literature DB >> 24998193

Ulcer healing after peripheral intervention-can we predict it before revascularization?

Nobuyoshi Azuma1, Atsuhiro Koya, Daiki Uchida, Yukihiro Saito, Hisashi Uchida.   

Abstract

Complete ulcer healing is one of the most important goals of treatment for critical limb ischemia; however, it is still difficult to inform patients of the time to ulcer healing before performing revascularization. The time to ulcer healing has a great impact on the cost of treatment and patient's quality of life. To predict it, the factors that influence delayed ulcer healing should be explored. According to a review of the literature investigating ulcer healing after revascularization, the influential factors can be classified into 5 categories: (1) systemic factors; (2) clinical state of tissue defect; (3) infection; (4) wound management strategy; and (5) revascularization strategy (endovascular or open repair, the angiosome concept). It is also important to ensure sufficient blood supply to predict ulcer healing probability in the individual patient. Several new methodologies, such as measuring tissue circulation around the tissue defect and intraoperative imaging techniques, have been reported. Because the status of ischemic tissue loss and wound healing ability can affect the decision-making process in selecting the revascularization strategy, understanding the many factors that influence ulcer healing after revascularization is indispensable for physicians performing revascularization. Accumulating ulcer healing data via well-designed clinical research can help to establish a new paradigm for the revascularization strategy from the viewpoint of ulcer healing.

Entities:  

Mesh:

Year:  2014        PMID: 24998193     DOI: 10.1253/circj.cj-14-0500

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Early-phase wound healing and long-term outcomes of a selective endovascular-first approach for treating Rutherford 5 critical limb ischemia with infrainguinal lesions.

Authors:  Kentaro Inoue; Toshihiro Onohara; Keita Mikasa; Tadashi Furuyama
Journal:  Surg Today       Date:  2016-04-18       Impact factor: 2.549

2.  Evaluation of graft anastomosis using time-intensity curves and quantitative near-infrared fluorescence angiography during peripheral arterial bypass grafting.

Authors:  Masaki Yamamoto; Hitoshi Ninomiya; Miwa Tashiro; Takayuki Sato; Takemi Handa; Keiji Inoue; Kazumasa Orihashi; Kazuhiro Hanazaki
Journal:  J Artif Organs       Date:  2018-11-22       Impact factor: 1.731

3.  Mobile Health-Based Thermometer for Monitoring Wound Healing After Endovascular Therapy in Patients With Chronic Foot Ulcer: Prospective Cohort Study.

Authors:  Donna Shu-Han Lin; Jen-Kuang Lee
Journal:  JMIR Mhealth Uhealth       Date:  2021-05-07       Impact factor: 4.947

4.  Recent Progress of Bypass Surgery to the Dialysis-Dependent Patients with Critical Limb Ischemia.

Authors:  Nobuyoshi Azuma; Shinsuke Kikuchi; Hiroko Okuda; Keisuke Miyake; Atsuhiro Koya
Journal:  Ann Vasc Dis       Date:  2017-09-25

Review 5.  Contemporary critical limb ischemia: Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care.

Authors:  Osami Kawarada; Kan Zen; Koji Hozawa; Shinobu Ayabe; Hsuan-Li Huang; Donghoon Choi; Su Hong Kim; Jiyoun Kim; Taku Kato; Yoshinori Tsubakimoto; Tasuya Nakama; Shigeo Ichihashi; Naoki Fujimura; Akihiro Higashimori; Masahiko Fujihara; Tomoyasu Sato; Bryan Ping-Yen Yan; Skyi Yin-Chun Pang; Chumpol Wongwanit; Yew Pung Leong; Benjamin Chua; Robbie K George; Yoshiaki Yokoi; Hisashi Motomura; Hideaki Obara
Journal:  Cardiovasc Interv Ther       Date:  2018-04-13

6.  Successful limb salvage through staged bypass combined with free gracilis muscle transfer for critical limb ischemia with osteomyelitis after failed endovascular therapy.

Authors:  Keisuke Miyake; Shinsuke Kikuchi; Hiroko Okuda; Atsuhiro Koya; Satomi Abe; Yoshiki Sawa; Tetsuo Ota; Nobuyoshi Azuma
Journal:  Surg Case Rep       Date:  2018-05-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.